As Tough Market And Policy Challenges Loom, J&J Names New India Leadership For Pharma Business
This article was originally published in PharmAsia News
Executive Summary
With former MSD hand Sanjiv Navangul as its new India CEO, experts believe J&J will make deeper inroads in the country. The new leader will be expected to make his way through regulatory bottlenecks at home while convincing global leadership to launch new drugs quickly for the Indian market.